Differential Cytokine Response in Host Defence Mechanisms Triggered by Gram-Negative and Gram-Positive Bacteria, and the Roles of Gabexate Mesilate, a Synthetic Protease Inhibitor
Open Access
- 1 April 2002
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 30 (2) , 99-108
- https://doi.org/10.1177/147323000203000201
Abstract
Bacterial infection results in the production of inflammatory mediators and may be involved in the pathogenesis of sepsis and/or systemic inflammatory response syndrome. The effect of lipopolysaccharide (LPS), a major component of the outer surface of Gram-negative bacteria, and Staphylococcal enterotoxin B (SEB), a superantigen of Gram-positive bacteria, on cytokine production in peripheral blood mononuclear cells (PBMCs) was examined. LPS significantly increased the production of proinflammatory and anti-inflammatory cytokines, and SEB enhanced the production of helper T lymphocyte type cytokines. These results illustrated the different responses to Gram-negative and Gram-positive bacterial infections. The effect of gabexate mesilate, a synthetic protease inhibitor, on cytokine production and expression of the toll-like receptor (TLR) was also examined. The results suggest that gabexate mesilate-induced inhibition of tumour necrosis factor-α (TNF-α) and interleukin-18 (IL-18) production in LPS-stimulated PBMCs is due to the inhibition of the nuclear factor-κB activation pathway and/or inhibition of the processing pathway of pro-TNF-α and pro-IL-18, not to down-regulation of TLR-2 or TLR-4.Keywords
This publication has 42 references indexed in Scilit:
- Staphylococcal enterotoxin B induces potent cytotoxic activity by intraepithelial lymphocytesImmunology, 2000
- Molecular basis of host—pathogen interaction in septic shockCurrent Opinion in Microbiology, 1998
- Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in ratsCritical Care Medicine, 1997
- Innate immunity: impact on the adaptive immune responseCurrent Opinion in Immunology, 1997
- Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytesCritical Care Medicine, 1996
- Current Understanding of SepsisClinical Infectious Diseases, 1996
- Effectiveness of gabexate mesilate in acute pancreatitisDigestive Diseases and Sciences, 1995
- Comparative study on the in vitro effectiveness of antithrombotic agentsThrombosis Research, 1991
- Approaching the Asymptote? Evolution and Revolution in ImmunologyCold Spring Harbor Symposia on Quantitative Biology, 1989
- Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsisCritical Care Medicine, 1983